DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Eichhorst B, Fink AM, Bahlo J. et al.
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol 2016;
17: 928-942
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.